Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caries Prevention Potential of Pearl Powder Versus Casein Phosphopeptide-amorphous Calcium Phosphate on Enamel White Spot Lesions: Randomized Clinical Trial.

NCT03973554 is registered in ClinicalTrials.gov with Ruba Alaa El Din Adel El Damarisy as lead sponsor.

NCT NCT03973554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03973554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caries Prevention Potential of Pearl Powder Versus Casein Phosphopeptide-amorphous Calcium Phosphate on Enamel White Spot Lesions: Randomized Clinical Trial.
Lead sponsor
Ruba Alaa El Din Adel El Damarisy
Phase
Phase 2
Overall status
Unknown status
Start date
October 30, 2019
Completion date
October 30, 2021
Enrollment
58 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

white spot lesion of tooth